Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00626821 · ClinicalTrials.gov registry record · Phase 4

Coloplast DialogueStudy

A Phase 4 study, sponsored by Coloplast A/S.

Completed
Registry status
Phase 4
Development phase
3,017
Enrollment target

NCT00626821 is a Phase 4 study that has completed, run by Coloplast A/S. The registered enrollment target is 3,017 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00626821, a Phase 4 study, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
Phase 4
Development phase
3,017 participants
Enrollment target

Study Summary

The main purpose of the study is to document real life experience on SenSura with focus on skin condition and quality of life.

Interventions

  • DEVICE SenSura

Trial Details

FieldValue
Enrollment Target 3,017 participants
Start Date 2008-02
Est. Completion 2010-12
Phase Phase 4

Sponsor

Coloplast A/S

21 total trials

What the Registry Record Tells You About NCT00626821

The ClinicalTrials.gov registry entry for NCT00626821 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 3,017 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which SenSura is the first listed.

NCT00626821 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00626821 about?

NCT00626821 is a clinical study titled "Coloplast DialogueStudy". The main purpose of the study is to document real life experience on SenSura with focus on skin condition and quality of life.

What is the current status of trial NCT00626821?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,017 participants. The study started on 2008-02. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00626821?

The interventions under investigation include: SenSura (DEVICE).

Who is sponsoring clinical trial NCT00626821?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.